The publication of University of Health Sciences Istanbul Sisli Hamidiye Etfal Application and Research Center.


Online article submission system has been turned over to eJManager. We kindly request you to submit your current article or new articles via eJManager system

          VOLUME 34 / ISSUE 1


The Journal is Indexed in


7 - L-Carnitene Effects On Anemia And The Response To Erythropoietin Treatment in Hemodialysis Patients

Yalçın Özbahar, Özçelik Okayer, Özlem Harmankaya, Aydoğan Öbek

OBJETIVE AND STUDY DESIGN: Although L-cartine administration has been slıown to result in an hematocrit in patients with end-stage renal disease, there is little data to demoııstrate that L-carnitene supplementation to hemodialysis patients under recombinant human erythropoietin (r-HuEPO) nıaintenance treatment could improve the response to-HuEPO treatment .To demonstrate whether L-carnitene treatment could furtlıer improve the anemia in dialyzed patients under r-HuEPO therapy, leading to a reduction in r-HuEPO reguirements, L-carnitene ( 1 g intravenously after every dialysis session) was administered for six months to a group of ten patients; the results were compared with datafrom placebo control group(n±IO).

RESULTS: L-carnitene treatment promoted 59% reduction in r-HuEPO (from 7000±2372 U/ week ıo,4900±3355 U/week;p<0,05 in placebo control group,r-HuEPO reguirements did not change signifıcantly (!rom 6400±2630 U/week ıo 7000±2610 U/ week;p> 0,05).

CONCLUSION: it is concludeddthat L-carnitene defıciency might promote EPO resistance in dialyzed patients which is corrected by L-carnitene supplementation, Ultimately reducing r-HuEPO reguirements.

Keywords:

To read full article click


Home Page       Editorial       Editorial Board       Advisory Board       Information for Authors       Contact       Archive

Copyright ® 2011 Sisli Etfal Hastanesi Tıp Bülteni